Building Efficiency into Biologics Formulations Development

Life Sciences, Pharmaceutical, Drug Discovery & Development, Drug Safety,
  • Wednesday, December 14, 2022 | 1pm EST (10am PST)
  • 60 min

Complex macromolecules are becoming a mainstay of pharmaceutical strategy, and the ability to successfully develop these biologics into viable commercial drugs is accelerating at a significant rate. Often, aggressive timelines are imposed on development projects with the aim of getting to First-in-Human trials as soon as possible. However, formulation development can be met with many challenges as biologics are often sensitive molecules with a variety of competing degradation possibilities.

Various approaches have been employed to expedite formulation decisions, yet there are many pros and cons to these approaches. Ultimately, the unified goal is to create a well-characterized pharmaceutical product with demonstrated safety and efficacy, and formulation development plays a critical role in this pursuit. Sharing of knowledge and best practices allows the entire community to build a foundation to achieve these goals and to advance science from curiosity to cure.

Join the featured speaker to explore biologics formulations development tools, tricks and methods and learn ways to utilize these in pragmatic and efficient ways.

Speaker

http://Tyler%20H.%20Jones

Tyler H. Jones, Director, Formulation, Curia Global, Inc.

Dr. Tyler Jones is the Director of Formulation at Curia, Camarillo, California, focused on formulation and cGMP fill/finish of injectable biologics. Dr. Jones has over a decade of experience in the biopharmaceutical industry with previous employment at companies including Nektar Therapeutics, Avanti Polar Lipids and Integrity Bio. His expertise is in the field of biologics formulation development and his PhD training was focused on protein biochemistry, structure/function and biophysics.

While at Curia – Camarillo, Dr. Jones has worked on development projects for over 80 unique molecules including proteins, peptides, nucleotides, lipid nanoparticles and more. He holds a PhD from the University of Alabama in Huntsville.

Message Presenter

Who Should Attend?

  • Formulations Scientists
  • Biologics CMC Personnel
  • Analytical R&D Staff
  • Research Scientists

What You Will Learn

Attendees will gain insights into:

  • Complexity of biologics formulations development and considerations of different approaches
  • Phase appropriate tools and tricks for building efficiency into formulation development programs

Xtalks Partner

Curia

Curia is a Contract Development and Manufacturing Organization with over 30 years of experience, an integrated network of 29 global sites and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate and sustain life-changing therapeutics. To learn more visit us at curiaglobal.com.

Media Partner

The original site for employees in the pharma, medical, diagnostic and related industries. Our hand-curated daily news feed and active message forums will keep you informed. 

You Must Login To Register for this Free Webinar

Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.

Create Account